SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-16-006411
Filing Date
2016-08-09
Accepted
2016-08-09 17:17:42
Documents
51
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ohrp-10q_063016.htm 10-Q 481194
2 CERTIFICATION OF CEO ex31-1.htm EX-31.1 11111
3 CERTIFICATION OF CFO ex31-2.htm EX-31.2 11158
4 CERTIFICATION OF CEO ex32-1.htm EX-32.1 5242
5 CERTIFICATION OF CFO ex32-2.htm EX-32.2 4902
  Complete submission text file 0001387131-16-006411.txt   2058858

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ohrp-20160630.xml EX-101.INS 237865
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ohrp-20160630.xsd EX-101.SCH 22099
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ohrp-20160630_cal.xml EX-101.CAL 40127
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ohrp-20160630_def.xml EX-101.DEF 74963
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ohrp-20160630_lab.xml EX-101.LAB 199009
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ohrp-20160630_pre.xml EX-101.PRE 158619
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 161819215
SIC: 2834 Pharmaceutical Preparations